In summary, we detected the IHC expression of ARID1A in gastric adenocarcinoma and explored the impact of ARID1A negative expression on prognosis and immune infiltration in combination with TCGA molecular classification. This evidence concerns the gene ARID1A and gastric adenocarcinoma.